Evidence map›Paper›PMID 20088595›Full record

ArticleBiochemistry2010

Analysis of monomeric and dimeric phosphorylated forms of protein kinase R.

Eric Anderson, Christine Quartararo, Raymond S Brown, Yu Shi, Xudong Yao, James L Cole

Open access · greenAbstract readComparative Study
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Heparin activates PKR by inducing dimerization.Journal of molecular biology · 2011
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eric AndersonDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut 06269, USA.
Christine Quartararo
Raymond S Brown
Yu Shi
Xudong Yao
James L Cole
University of Connecticut · US

Funding

Mechanism for Activation of the Antiviral Kinase PKRR01AI053615 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI COLE, JAMES L · 2004 to 2016
$3.9M
NIAID NIH HHS AI-53615NIAID NIH HHS R01 AI053615
6 · The paper itself

Abstract

PKR (protein kinase R) is induced by interferon and is a key component of the innate immunity antiviral pathway. Upon binding double-stranded RNA (dsRNA) or dimerization in the absence of dsRNA, PKR undergoes autophosphorylation at multiple serines and threonines that activate the kinase. Although it has previously been demonstrated that phosphorylation enhances PKR dimerization, gel filtration analysis reveals a second monomeric phosphorylated form. These forms are termed phosphorylated dimeric PKR (pPKRd) and phosphorylated monomeric PKR (pPKRm). These two forms do not reversibly interconvert. Sedimentation equilibrium measurements reveal that pPKRm dimerizes weakly with a K(d) similar to that of unphosphorylated PKR. Isoelectric focusing and mass spectrometry demonstrate that both pPKRm and pPKRd are heterogeneous in their phosphorylation states, with an average of 9 or 10 phosphates. Equilibrium chemical denaturation analysis indicates that phosphorylation destabilizes the kinase domain by approximately 1.5 kcal/mol in the dimeric form but not in the monomeric form. Limited proteolysis also reveals that phosphorylation induces a conformational change in pPKRd that is not detected in pPKRm. pPKRm binds dsRNA with an affinity similar to that of unphosphorylated PKR, whereas binding cannot be detected with pPKRd. Despite these substantial differences in biophysical properties, both pPKRm and pPKRd are catalytically competent and are activated to phosphorylate the PKR substrate eIF2alpha in the absence of dsRNA. Thus, both monomeric and dimeric forms of phosphorylated PKR may participate in the interferon antiviral pathway.

Indexed as

Protein MultimerizationAntiviral AgentsCatalysisChromatography, GeleIF-2 KinaseEukaryotic Initiation Factor-2InterferonsIsoenzymesPhosphorylationSignal TransductionSubstrate SpecificityAntiviral AgentseIF-2 KinaseEukaryotic Initiation Factor-2InterferonsIsoenzymes

Identifiers

PMID20088595
PMCPMC2819637
OpenAlexW2088711581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.